carvedilol has been researched along with furafylline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akao, T; Hashimoto, Y; Ishida, K; Taguchi, M | 1 |
| Iwaki, M; Kawase, A; Komura, H; Nakamura, Y; Niwa, T | 1 |
2 other study(ies) available for carvedilol and furafylline
| Article | Year |
|---|---|
Involvement of the CYP1A subfamily in stereoselective metabolism of carvedilol in beta-naphthoflavone-treated Caco-2 cells.
Topics: Adrenergic beta-Antagonists; beta-Naphthoflavone; Caco-2 Cells; Carbazoles; Carvedilol; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Glucuronides; Humans; Microsomes; Oxidation-Reduction; Propanolamines; RNA, Messenger; Stereoisomerism; Theophylline | 2009 |
Relative contribution of rat CYP isoforms responsible for stereoselective metabolism of carvedilol.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Carbazoles; Carvedilol; Catalysis; Cells, Cultured; Cytochrome P-450 CYP3A; Humans; Insecta; Isoenzymes; Male; Microsomes, Liver; Oxidation-Reduction; Propanolamines; Quinine; Rats; Rats, Sprague-Dawley; Stereoisomerism; Theophylline | 2018 |